http://dspace.bsu.edu.ru/handle/123456789/63417| Title: | Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice |
| Authors: | Borozdina, N. A. Kazakova, E. N. Gladkikh, I. N. Leychenko, E. V. Dyachenko, I. A. |
| Keywords: | medicine pharmacology acarbose α-amylase inhibitors insulin type 2 diabetes mellitus C57BL/6 mice |
| Issue Date: | 2024 |
| Citation: | Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice / N.A. Borozdina, E.N. Kazakova, I.N. Gladkikh [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №2.-P. 65-72. - Doi: 10.18413/rrpharmacology.10.455. - Refer.: p. 71. |
| Abstract: | α-amylase inhibitors are an important class of second-line antihyperglycemic drugs. They slow down the breakdown and absorption of carbohydrates, reducing peak glucose concentration with meals. Recent reports have also shown other beneficial effects of α-amylase inhibitors on type 2 diabetes mellitus (T2DM) |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/63417 |
| Appears in Collections: | Vol. 10, № 2 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Borozdina_Long-term_24.pdf | 434.78 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.